McNeel Eye Center Corneal Crosslinking Study

Running, not enrolling · Not applicable

Conditions studied: Keratoconus

In brief

This study will investigate the effectiveness in treating keratoconus, pellucid marginal degeneration and post LASIK iatrogenic ectasia utilizing fluence rates and treatment times of Corneal Cross Linking other than the original FDA approved protocol of 3mw/cm2.

Key facts

Study ID

NCT02921009

Run by

McNeel Eye Center

People needed

100

Starts

2016-09-01

Expected to finish

2025-12-31

Last updated by the study team

2025-04-06

Who can join

Age: 15 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males or females between the ages of 15 and 50 with keratoconus diagnosed topographically with or without other corneal ectatic disease.

You may not qualify if…

• Prior corneal transplantation, pregnancy, inability or unwillingness to adhere to follow up protocol.

Where it is running

• McNeel Eye Center — Boise, Idaho, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.